Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Persistent infection with human papillomavirus (HPV) initiates ~5% of all human cancers, and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection, but do not eliminate existing HPV infections. Papillomaviruses induce hyperproliferation of epithelial cells. In this revi...
Main Authors: | Chenhao Zhou, Zewen Kelvin Tuong, Ian Hector Frazer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00682/full |
Similar Items
-
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
by: Antonio Carlos de Freitas, et al.
Published: (2017-05-01) -
Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
by: Takashi Hatano, et al.
Published: (2021-04-01) -
Detection of Human Papillomaviruses in the Nasopharynx of Breastfed Infants: New Findings and Meta-Analysis
by: Luisa Dassi, et al.
Published: (2020-10-01) -
Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins
by: Irene Lo Cigno, et al.
Published: (2020-04-01) -
Distribution of Human Papilloma Virus-16 E7 oncoprotein in Iranian Patients with Cervix Cancer
by: Ahmad Piroozmand, et al.
Published: (2018-01-01)